EBS

Emergent BioSolutions
EBS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$339.24M
EV
$862.84M
Shares Outstanding
54.28M
Beta
2.11

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$13.50
P/E 2025E
7.56x
P/Revenue 2025E
0.42x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Emergent BioSolutions Inc.

gainify
EBS

Emergent BioSolutions Inc.

EBS

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Papa, Joseph

Employees

900

IPO Date

2006-11-15

Headquarters

400 Professional Drive, Suite 400, Gaithersburg, Maryland, 20879, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.